Effect of 5-azacytidine: Evidence for alteration of the multipotent ability of mesenchymal stem cells

Stem Cells and Development

Volumn 20, Issue 7, 2011, Pages 1213-1221

  Rosca, Ana Maria ^a   Burlacu, Alexandrina ^a,b  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; HEART DISEASE; HEART MUSCLE CELL; HUMAN; MESENCHYMAL STEM CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; AZACITIDINE; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; MESENCHYMAL STEM CELLS; MICE; MULTIPOTENT STEM CELLS; MUSCLE CELLS; MUSCLE DEVELOPMENT; MYOCYTES, CARDIAC; OSTEOGENESIS; TRANSCRIPTIONAL ACTIVATION;

EID: 79955915974     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0433     Document Type: Article

References (31)

1. Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705. (Pubitemid 32290358)
2. Kudo M, Y Wang, MA Wani, M Xu, A Ayub and M Ashraf. (2003). Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 35:1113-1119. (Pubitemid 37083255)
3. Balsam LB, AJ Wagers, JL Christensen, T Kofidis, I Weissman and RC Robbins. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673. (Pubitemid 38524811)
4. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
5. Tomita S, R-K Li, RD Weisel, DAC Mickle, E-J Kim, T Sakai and Z-Q Jia. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II256. (Pubitemid 29523543)
6. Liu Y, J Song, W Liu, Y Wan, X Chen and C Hu. (2003). Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc Res 58:460-468. (Pubitemid 36570404)
7. Martin-Rendon E, D Sweeney, F Lu, J Girdlestone, C Navarrete and SM Watt. (2008). 5-Azacytidine-treated human mesenchymal stem=progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 95:137-148. (Pubitemid 351951902)
8. Taylor SM and PA Jones. (1979). Multiple new phenotypes induced in 10T1=2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779. (Pubitemid 9252286)
9. Bel A, E Messas, O Agbulut, P Richard, J-L Samuel, P Bruneval, AA Hagège and P Menasché. (2003). Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108:II247-II252. (Pubitemid 37099963)
10. Burlacu A, A-M Rosca, H Maniu, I Titorencu, E Dragan, V Jinga and M Simionescu. (2008). Promoting effect of 5- azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur J Cell Biol 87:173-184. (Pubitemid 351250639)
11. Chamberlain G, K Wright, A Rot, B Ashton and J Middleton. (2008). Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One 3:e2934-e2939.
12. Glassford AJ, P Yue, AY Sheikh, HJ Chun, S Zarafshar, DA Chan, GM Reaven, T Quertermous and PS Tsao. (2007). HIF- 1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 293:E1590-E1596. (Pubitemid 350255108)
13. Tropel P, D Noël, N Platet, P Legrand, AL Benabid and F Berger. (2004). Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295:395-406. (Pubitemid 38490494)
14. Kassis I, L Zangi, R Rivkin, L Levdansky, S Samuel, G Marx and R Gorodetsky. (2006). Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37:967-976. (Pubitemid 43792558)
15. Baddoo M, K Hill, R Wilkinson, D Gaupp, C Hughes, GC Kopen and DG Phinney. (2003). Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89:1235-1249. (Pubitemid 36959389)
16. Cao Y, Z Sun, L Liao, Y Meng, Q Han and RC Zhao. (2005). Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332:370-379. (Pubitemid 40724988)
17. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
18. Zipori D. (2004). Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis 33:211-215. (Pubitemid 39446488)
19. Yoshida N, S Yoshida, K Koishi, K Masuda and Y Nabeshima. (1998). Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci 111:769-779. (Pubitemid 28163885)
20. Forte G, M Minieri, P Cossa, D Antenucci, M Sala, V Gnocchi, R Fiaccavento, F Carotenuto, P de Vito, PM Baldini, M Prat and P Di Nardo. (2006). Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24:23-33.
21. Cerny J and PJ Quesenberry. (2004). Chromatin remodeling and stem cell theory of relativity. J Cell Physiol 201:1-16. (Pubitemid 39187040)
22. Larsen F, G Gundersen, R Lopez and H Prydz. (1992). CpG islands as gene markers in the human genome. Genomics 13:1095-1107.
23. Konieczny SF and CP Emerson. (1984). 5-azacytidine induction of stable mesodermal stem cell lineages from 10T1=2 cells: evidence for regulatory genes controlling determination. Cell 38:791-800. (Pubitemid 15176109)
24. Choi SC, J Yoon, WJ Shim, YM Ro and DS Lim. (2004). 5- Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 36:515-523. (Pubitemid 40129173)
25. Kehat I, D Kenyagin-Karsenti, M Snir, H Segev, M Amit, A Gepstein, E Livne, O Binah, J Itskovitz-Eldor and L Gepstein. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407-414. (Pubitemid 32730787)
26. Burlacu A. (2006). Can 5-azacytidine convert the adult stem cells into cardiomyocytes? A brief overview. Arch Physiol Biochem 112:260-264. (Pubitemid 46018368)
27. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
28. Tomita S, R-K Li, R Weisel, DA Mickle, EJ Kim, T Sakai and ZQ Jia. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II56.
29. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J-I Hata, A Umezawa and S Ogawa. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705. (Pubitemid 29122423)
30. Blau HM, TR Brazelton and JM Weimann. (2001). The evolving concept of a stem cell: entity or function? Cell 105:829-841. (Pubitemid 32635085)
31. Zuscik MJ, JF Baden, Q Wu, TJ Sheu, EM Schwarz, H Drissi, RJ O'Keefe, JE Puzas and RN Rosier. (2004). 5-Azacytidine alters TGF-b and BMP signaling and induces maturation in articular chondrocytes. J Cell Biochem 92:316-331.